Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (156K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Wisniewski, J
Right arrow Articles by Wu, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wisniewski, J
Right arrow Articles by Wu, C
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press 367-375

The C-terminal region of Drosophila heat shock factor (HSF) contains a constitutively functional transactivation domain

The C-terminal region of Drosophila heat shock factor (HSF) contains a constitutively functional transactivation domain Jan Wisniewski , András Orosz , Ravi Allada and Carl Wu*

Laboratory of Biochemistry, National Cancer Institute, National Institutes of Health, Building 37, Room 4C09, Bethesda , MD 20892, USA

* To whom correspondence should be addressed

Received August 10, 1995; Revised and Accepted November 30, 1995

ABSTRACT

The heat shock transcription factor (HSF) is constitutively expressed in Drosophila cells as an inactive monomer. Upon heat shock HSF undergoes trimerization and acquires high affinity DNA binding ability, leading to specific interaction with its cognate elements in heat shock promoters. Here we show that the transactivation function of HSF is conferred by the extreme C-terminal region of the protein. Deletion analysis of HSF fragments fused to the GAL4 DNA-binding domain demonstrates that transactivation is dependent on HSF residues 610-691. This domain is located beyond the C-terminal heptad repeat (leucine zipper 4) whose presence or integrity is dispensable for transactivation. The transactivation domain is functional in the absence of heat shock and can be replaced by the extreme C-terminal region of human HSF1. The Drosophila and human HSF transactivation domains are both rich in hydrophobic and acidic residues and may be structurally conserved, despite limited sequence identity.

INTRODUCTION

In the cells of all organisms studied to date, a sudden increase in the ambient temperature or treatment by a variety of other environmental stresses activates a small set of so-called heat shock genes [for reviews see ( 1 - 6 )]. In eukaryotes, this response is regulated by a transcriptional activator called heat shock factor (HSF) [for recent reviews see ( 7 - 10 )] which interacts with sets of at least three inverted AGAAN repeats (heat shock elements or HSEs) present in heat shock promoters ( 11 - 16 ). With the exception of budding yeast, HSF exists in cells in a cryptic form as an inactive monomer and acquires high DNA-binding affinity by the means of trimerization after stress induction ( 17 - 23 ). Such activated HSF gains also transcriptional competence and undergoes hyperphosphorylation. In some instances uncoupling of DNA binding and transcriptional activities was observed which suggested that these two events could be regulated independently ( 24 , 25 ).

The DNA binding activity of metazoan HSF is subjected to negative control. When expressed in bacteria, recombinant HSF constitutively forms trimers even at non-heat shock temperatures ( 26 , 27 ). Latent, heat-shock inducible HSF molecules accumulate however, when the protein is expressed in frog oocytes ( 28 ), tissue culture cells ( 18 , 29 , 30 ) or in reticulocyte lysates ( 31 ). The temperature threshold of heat shock-dependent activation of HSF is affected by the intracellular environment as shown by the behavior of human HSF1 protein expressed in Drosophila cells ( 29 ), tobacco protoplasts ( 30 ) and Xenopus oocytes ( 28 , 32 ) as well as by the effect of temperature adaptation on endogenous human HSF1 ( 33 ). These data suggest that factors present in eukaryotic cells are required for suppressing the assembly of HSF trimers under normal conditions. One of possible means of HSF suppression is through interactions with hsp70. An association between HSF and hsp70 was observed both under normal conditions and after heat stress and the overexpression of heat shock proteins facilitates the kinetics of HSF trimer dissociation ( 34 - 39 ). The exact effect of heat shock proteins on HSF activity and conformation awaits further characterization.

In the budding yeast Saccharomyces cerevisiae and Kluyveromyces lactis the regulation of HSF DNA binding activity is largely bypassed and HSF is constitutively able to interact with heat shock promoters ( 20 , 40 - 43 ). In these cases, heat shock stimulates the transactivation function of promoter-bound HSF trimers and hyperphosphorylation of serine and threonine residues ( 44 ). The transactivation ability of budding yeast HSF is localized in two separate domains broadly located near N-terminus and C-terminus, respectively ( 45 , 46 ). The C-terminal transactivation domain was shown to overlap a leucine zipper-like motif ( 47 ) and its activity is influenced by other parts of protein including a conserved heptapeptide (CE2), the oligomerization domain as well as DNA binding domain ( 45 , 46 , 48 - 50 ). These regions suppress transactivation under non-stress conditions and specific mutations in those domains cause constitutive activation of heat shock promoters. In addition, the effects of mutations in two yeast hsp70 genes demonstrate that hsp70 may also be involved directly or indirectly in maintaining HSF in a transcriptionally suppressed state ( 51 ).

Studies of metazoan HSFs have concentrated mainly on sequences important for DNA binding and trimer formation. Regions responsible for transactivation were characterized only for tomato HSF proteins ( 30 ) and recently for human HSF1 ( 52 ). In this paper we identify a C-terminal fragment of Drosophila HSF necessary for efficient activation of a target promoter using chimeric molecules comprised of HSF segments fused to the GAL4 DNA binding domain. We also demonstrate that the corresponding region of human HSF1 harbors a potent transactivation domain active in Drosophila cells despite lack of obvious homology at the protein sequence level.


Figure 1 . Structure of chimeric GAL4 genes. The coding region of the Drosophila HSF gene is schematically depicted on the top, and regions encoding known functional domains as well as restriction sites used for subcloning are indicated. HSF fragments present in corresponding GAL4-HSF constructs are aligned below and their coordinates are given after the construct number. The GAL4 DNA-binding domain (amino acids 1-147) is represented by a grey box and the VP16 transactivation domain (amino acids 414-490) is shown as a black box. The fragment derived from human HSF1 (amino acids 385-529) is surrounded by a thick line. Internal deletions inside HSF fragments are indicated by dashes and any additional amino acids generated at subcloning junctions are listed in a one-letter code. The CAT activity for each construct is normalized to the DNA binding activity and given on the right as a % of the CAT activity of GAL4-VP16 (pGVP16).

MATERIALS AND METHODS

Plasmids

All effector plasmids were constructed in the pRmHa3 vector containing the Drosophila metallothionein promoter and the alcohol dehydrogenase 3' untranslated region ( 29 ). To generate control constructs pG and pGVP16, the region encoding the GAL4 DNA-binding domain (codons 1-147, Eco RI- Bgl II fragments) alone or together with the VP16 transactivation domain (codons 413-490, Eco RI- Bam HI fragment) was transferred into Eco RI- Bam HI site of the pRmHa3 vector from plasmid pSGGal4VP16 ( 53 ). GAL4-HSF chimeras were made by inserting various fragments of Drosophila HSF gene from plasmid pRmHSF20 downstream of the GAL4 DNA-binding domain coding sequence (see below and Fig. 1 for details). C-terminal and internal deletions were generated using convenient restriction sites or by means of PCR, utilizing primers containing type II restriction enzyme Sap I recognition sequences, thus avoiding generation of additional codons at the junctions. PCR-derived regions and all subcloning junctions were verified by sequencing. Details of subcloning are listed below (refer to Fig. 1 for the restriction map):

Construct I . Blunted Bst BI- Bam HI fragment of the Drosophila HSF gene was inserted into blunted Nhe I (generated by filling original Hin dIII site)- Bam HI sites of plasmid pG.

Constructs II-IV and VI . Stu I- Bam HI fragment of PCR products generated using a forward primer: 5'-GGGAATTCAAA ATG AGGTCGCGTTCATCC-3' corresponding to region around amino acid 1 (codon underlined) of Drosophila HSF, and reverse primers: for construct II primer 5'-CGCGGATCCTTA CCT TGGCCTCCTGGTCATT-3' corresponding to the region around amino acid 674 (codon underlined) of Drosophila HSF, for construct III primer 5'-CGCGGATCCTTA ATA CATGGGCTGATAGGAAA-3' corresponding to the region around amino acid 655 (codon underlined) of Drosophila HSF, for construct IV primer 5'-CGCGGATCCTTA TAG GCCATAGTTGTCCATTAG-3' corresponding to the region around amino acid 629 (codon underlined) of Drosophila HSF and for construct VI primer 5'-CGCGGATCCTTA CAG CAGATCCTTCAGTGTTT-3' corresponding to region around amino acid 602 (codon underlined) of Drosophila HSF were subcloned into Stu I- Bam HI site of construct I.

Construct V. Bcl I- Bam HI fragment of construct I was excised, ends filled and ligated.

Construct VII. Blunted Bst BI- Bam HI fragment of the Drosophila HSF C-terminal deletion mutant 1-585 (Clos et al ., 1993) was subcloned as in construct I.

Construct VIII. Stu I- Bam HI fragment was excised from construct I, ends filled and ligated.

Construct IX. Blunted Nco I- Bam HI fragment of the Drosophila HSF gene was inserted into blunted Hin dIII- Bam HI sites of plasmid pG.

Construct X. Blunted Afl III- Bam HI fragment of the Drosophila HSF gene was subcloned as in construct I.

Construct XI. Blunted Bsp EI- Bam HI fragment of the Drosophila HSF gene was subcloned as in construct I.

Construct XII. Stu I- Bam HI fragment of the Drosophila HSF gene was subcloned as in construct I.

Constructs XIII-XVI. Acc I- Bcl I fragment was excised from constructs I-IV, respectively, ends filled and ligated.

Construct XVII. PCR fragments of the human HSF1 gene coding residues 384-529 (forward primer 5'-TAT GCTCTTC ACTCAGTGACCACTTGGATGCT-3' and a reverse primer 5'-CGGGATCCTAGGAGACAGTGGGGAC-3') and the Drosophila HSF gene coding for residues 1-583 (forward primer used for constructs II-IV and VI above, and a reverse primer 5'-TAT GCTCTTC AGAGTTCGTCAACTGAGGCCAT-3') were digested with Sap I (recognition sites in primers are underlined), ligated and then Afl III- Bam HI fragment of ligation product was cloned to substitute for the corresponding region of construct I.


Figure 2 . Chimeric GAL4-HSF proteins are expressed in transfected Drosophila cells. Schneider line 2 cells were transfected with 5 [mu]g of plasmid DNA. Expression of chimeric genes was induced for 16 h with 0.7 mM CuSO 4 . Cells were then directly solubilized in SDS-sample buffer and resulting lysates (2% of total volume) were analyzed by SDS-PAGE (7-14% gradient gel) followed by Western blotting and ECL detection. Recombinant GAL4 proteins were visualized using monoclonal antibody against the DNA-binding domain of yeast GAL4 protein ( A ) as well as with anti- Drosophila HSF polyclonal antibody ( B ). A specific monoclonal antibody was also used to check levels of heat shock cognate hsc70 protein ( C ). Positions of protein standards (in kDa) are marked on the left side of the panels. The size of recombinant GAL4-HSF proteins is roughly proportional (but always somewhat larger) than the molecular weight derived from their amino acid composition. A similar difference is observed for Drosophila HSF (22,26). Both pG and pGVP16 samples in (A) show an additional cross-reacting polypeptide, possibly dimers of the GAL4-HSF chimeras caused by incomplete reduction during sample preparation for SDS-PAGE.

Reporter plasmid pG 5 BCAT is described elsewhere ( 53 ). All plasmids were purified using alkaline lysis followed by ethidium bromide/CsCl gradient ultracentrifugation.

Antibodies

Rabbit polyclonal antibody 943 against Drosophila HSF was described previously ( 22 ). Murine monoclonal antibody RK5C1 against GAL4 DNA-binding domain were obtained from Santa Cruz Biochemicals. Murine monoclonal antibody 3a3, cross-reacting with Drosophila hsc70 was purchased from Affinity Bioreagents. Secondary antibodies conjugated with horseradish peroxidase (donkey anti-rabbit IgG-HRP and sheep anti-mouse IgG-HRP) were obtained from Amersham and Chemicon, respectively. Fluorescein labeled anti-mouse IgG and rhodamine-labeled anti-rabbit IgG were from Jackson Laboratories.

Cell culture and transfection

Drosophila Schneider line 2 cells were cultured in serum-free HyQ-CCM3 medium (Hyclone) in tightly closed flasks at 22oC. For transfection 3.5 ml of 1:5 dilution of a dense culture were seeded into each 25 cm 2 flask and cells were allowed to grow for 24 h, medium was then replaced and DNA-lipofectin complexes were added [~5 [mu]g of total plasmid DNA diluted to 20 [mu]l with water and mixed with 30 [mu]l of lipofectin (Gibco/BRL)]. Expression of transfected GAL4-HSF constructs was induced with 0.7 mM CuSO 4 as specified ( 54 ). Cells in flasks were washed once with PBS, then fresh medium was added and, to induce the heat shock response, tightly closed flasks were submerged for 20 min in a water bath set to 37.5oC. When necessary, cells were allowed to recover at room temperature for 90 min. The flasks were chilled, cells were scraped, the cell suspension was aliquoted into three Eppendorf tubes and centrifuged for 30 s at 12 000 r.p.m. Cell pellets were immediately frozen on dry ice and stored at -80oC.

Western blotting

Samples of whole cell extracts or cells directly solubilized in SDS-sample buffer were subjected to SDS-PAGE and electroblotted onto nitrocellulose. Filters were blocked with 5% powdered skim milk (Difco) in PBS/0.1% Tween 20. Primary antibodies were diluted 1:5000-1:20 000 in PBS/0.1% Tween 20 containing 0.5% BSA and filters were incubated for 1 h at room temperature. After rinsing twice with water and washing 2 * 5 min with PBS/0.1% Tween 20, filters were incubated for 1 h with secondary antibody diluted 1:20 000 in PBS/0.1% Tween 20 containing 0.5% BSA. Blots were then rinsed twice with water and 4 * 3 min with PBS/0.1% Tween 20, and developed with ECL reagents (Amersham).

Immunostaining

Cells were grown, transfected and heat-shocked in 9 cm 2 chamber slides (Nunc), washed with ice-cold PBS and fixed in 4% formaldehyde in PBS on ice for 10 min, washed with PBS and incubated in methanol for 20 min. After washing four times in cold PBS, slides were incubated in a mixture of primary antibodies (1:500 in PBS containing 0.5% BSA) for 1 h, then washed again four times in PBS and incubated for 1 h in a mixture of secondary antibodies (1:500 in PBS containing 0.5% BSA). Then slides were washed with PBS, stained with Hoechst 33258, washed again, dried in the darkness, mounted and analyzed under the fluorescence microscope.

CAT assay

Cells cotransfected with GAL4-HSF constructs and pG 5 BCAT plasmid were disrupted in 200 [mu]l of 0.25 M Tris-HCl, pH 7.5 by three cycles of freezing and thawing (dry ice and 37oC, respectively). Samples were centrifuged at 12 000 r.p.m. at 4oC and supernatant was stored at -80oC until analyzed. For assay, 1 [mu]l of supernatant was mixed with 2.5 [mu]l of [ 14 C]-chloramphenicol and 5 [mu]l of acetyl-coenzyme A in a total volume of 37.5 [mu]l (adjusted with 0.25 M Tris-HCl, pH 7.5). Samples were incubated at 37oC for 30 min, then chilled on ice, supplemented with 70 [mu]l 0.25 M Tris-HCl pH 7.5 and extracted with 1 ml of ethyl acetate. Organic phase (0.9 ml) was collected after a brief centrifugation, dried in a Speed-Vac, dissolved in 15 [mu]l of ethyl acetate and spotted onto a TLC silica gel plate. After chromatography in chloroform:methanol (95:5) mixture, the plate was air-dried and analyzed by autoradiography.


Figure 3 . GAL4-HSF proteins are located in cell nucleus. Transfection of Schneider line 2 cells was conducted directly in 9 cm 2 slide flasks and cells were treated as described in Figure 2 legend. Fixed cells were incubated simultaneously with primary antibodies to yeast GAL4-DBD (mouse monoclonal) and Drosophila HSF (rabbit polyclonal), followed by secondary antibodies against murine IgG (fluorescein) and rabbit IgG (rhodamine), and then stained for DNA with Hoechst 33258 dye. Cells were analyzed by fluorescence microscopy.

Electrophoretic mobility shift assay

Whole cell extracts were prepared and gel mobility shift analysis was carried out as described previously ( 55 ) using [ 32 P]-5'-end-labeled double-stranded oligonucleotides corresponding to heat shock element (HSE):

5"-GGGCAGAATCTTCTAGAATCAGC-3"

3"- CGTCTTAGAAGATCTTAGTCGGG-5"

or the GAL4 binding site:

5"-AATTCGGTCGGAGTACTGTCCTCCGACTCT-3"

3"- GCCAGCCTCATGACAGGAGGCTGAGAGATC-5"

Reaction mixtures were incubated for 10 min on ice (HSE oligonucleotide) or at room temperature (GAL4 binding site oligonucleotide) before loading onto 0.8% agarose/0.5* TBE gel. After electrophoresis gels were dried onto DEAE paper (DE81, Whatman) and autoradiographed.

RESULTS

Expression of GAL4-HSF chimeras in transfected Drosophila cells

In order to exclude the activity of the endogenous Drosophila HSF from interfering with analysis of mutant Drosophila HSF proteins expressed by DNA transfection, we have resorted to chimeric HSF molecules whereby the DNA binding domain of HSF is substituted with the DNA binding domain of the yeast transcriptional factor GAL4. The use of GAL4 ensures both constitutive DNA binding to target DNA sequences as well as nuclear localization of the chimeric proteins ( 56 - 58 ). To further avoid the potential formation of mixed trimers between GAL4-HSF and endogenous HSF, the trimerization domain of HSF was also removed in the GAL4 chimeras. Hence, the hybrid genes we constructed carry the region encoding the C-terminal half of Drosophila HSF.

Figure 1 presents schematic structure of different GAL4-HSF constructs used in our study. Plasmids containing these inserts were transfected into Drosophila Schneider line 2 (SL-2) cells and the expression of chimeric proteins was induced by adding 0.7 mM Cu 2+ for 16 h, conditions which do not induce the endogenous heat shock genes ( 54 ). The efficiency of transfection was ~25-30% as estimated by immunostaining with anti-GAL4 antibody (data not shown, see also Fig. 3 ). Figure 2 shows a Western blot analysis of transfected cells directly lysed in SDS-sample buffer. A monoclonal antibody specific for the DNA binding domain of yeast GAL4 protein shows the expression of a number of GAL4-HSF chimeras (Fig. 2 A, lanes 4-9, arrowheads). Analysis of the same blot with polyclonal anti- Drosophila HSF antibody (Fig. 2 B) reveals that the indicated proteins contain HSF fragments and thus truly represent chimeric GAL4-HSF. In relation to the expression of the endogenous Drosophila HSF, the overall expression levels of the GAL4-HSFs are greater by several-fold, although there are fluctuations between different GAL4-HSF constructs. Analysis of the same Western blot with anti-hsc70 antibody in Figure 2 C confirms equal protein loading in every lane.


Figure 4 . DNA binding activity of GAL4-HSF proteins is not affected by heat shock. Cells were transfected as described in Figure 2 legend. Whole-cell extracts (0.4% of total volume) prepared from control cells (-) and from cells subjected to heat shock (+) (20 min at 37oC) were analyzed for DNA-binding activity using electrophoretic mobility shift assay with the GAL4 binding site and HSE oligonucleotides ( A and B , respectively). Position of free oligonucleotide (F) and protein-oligonucleotide complex (B) is indicated on the left side of the panels. Western blot analysis of the same samples showed that comparable amounts of recombinant proteins were extracted from both control and heat shocked cells (not shown).


Figure 5 . Transactivation domain of Drosophila HSF is localized C-terminal to leucine zipper 4. ( A ) CAT assays were carried out on extracts (0.14% of the total volume) prepared from SL-2 cells cotransfected with 0.1 [mu]g of GAL4-HSF encoding plasmids and 5 [mu]g of pG 5 BCAT. Expression of GAL4-HSF chimeras was induced for 6 h, cells were then heat shocked for 20 min at 37oC and allowed to recover at room temperature for 90 min prior to extraction. TLC plates were exposed to X-ray film for 17 h. ( B ) Presence of GAL4-HSF chimeras (bands indicated with arrowheads) was checked with anti-HSF antibody on a Western blot prepared from samples of cells directly solubilized in SDS-sample buffer lysate (0.7% of total volume). Construct XIII is barely detectable because of the very short HSF segment present. The level of chimeric proteins was also followed by the electrophoretic mobility shift essay ( C ) using whole cell extracts prepared from cotransfected cells (3% of total volume). Positions of free radioactive GAL4 binding site oligonucleotide and probe complexed by GAL4-HSFs are marked as `F' and `B', respectively. The location of the C-terminal activator (CTA) is shown.

GAL4-HSF chimeras are localized in the nucleus

To determine the subcellular distribution of chimeric GAL4-HSF proteins, transfected SL-2 cells were analyzed by indirect immunofluorescence. Figure 3 shows representative examples of such staining of unshocked cells. The GAL4 DNA-binding domain was always localized in interphase cell nuclei of cells transfected with plasmid pG carrying the GAL4 DNA binding domain only, as confirmed by staining for DNA. That distribution pattern is identical to the nuclear localization of the endogenous HSF in both transfected (GAL4 positive) and non-transfected (GAL4 negative) cells. Nuclear localization in the absence of heat stress was observed for representative GAL4-HSF chimeras (constructs I and VI; Fig. 3 ). In these cases the transfected cells also show increased staining with anti-HSF antibody. All other GAL4-HSF constructs were analyzed, and the subcellular distribution of the GAL4 chimeric proteins was found to be nuclear in the absence of heat shock and that distribution was not changed by heat stress (data not shown).


Figure 6 . Analysis of the C-terminal transactivation domain in absence of internal region. ( A ) CAT activity was assayed in cells cotransfected with the indicated constructs (top). TLC plates were exposed to X-ray film for 17 h. ( B ) Presence of chimeric CAL4-HSF proteins was detected by electrophoretic mobility shift assay using the radiolabeled GAL4 binding site (see Fig. 5 legend for experimental details).


Figure 7 . Transactivation domain of Drosophila HSF is not stimulated by heat shock and can be substituted by C-terminal region of human HSF1. ( A ) Schneider line 2 cells were cotransfected with 0.1 [mu]g of indicated GAL4-HSF plasmids and 5 [mu]g of pG 5 BCAT plasmid. Extracts were prepared from control or heat shock cells (`-' and `+', respectively) and equal volumes (0.14%) of extracts were used for CAT assay. The TLC plate was exposed to X-ray film for 16 h. ( B ) Cells were cotransfected with pG 5 BCAT and GAL4 Drosophila HSF constructs I and XVII (see Fig. 1). The expression of GAL4-HSF proteins was induced for 2.5 h prior to heat stress. The TLC plate was exposed to X-ray film for 30 h to measure CAT activity.

Chimeric proteins bind to target DNA in the absence of heat stress

To analyze the DNA-binding activity of GAL4-HSF chimeras, whole cell extracts were prepared from transfected cells. Electrophoretic mobility shift analysis indicated that these proteins recognize target DNA constitutively and representative examples are shown in Figure 4 A. As Western blot analysis showed that chimeric proteins are equally well extracted from cells before and after heat shock (data not shown), the specific DNA binding activity of GAL4-HSF chimeras is not affected by heat stress. This contrasts with heat inducible DNA-binding activity displayed by endogenous HSF in the same extracts (Fig. 4 B). A similar constitutive DNA binding activity was found for the other GAL4-HSF constructs (data not shown).

Transcriptional activation is mediated by extreme C-terminal region of Drosophila HSF

To identify regions of Drosophila HSF responsible for transactivation, GAL4-HSF constructs were cotransfected into SL-2 cells with a CAT reporter gene controlled by a GAL4-responsive promoter ( 53 ). The expression of chimeric GAL4-HSF factors was induced with 0.7 mM Cu 2+ for 6 h, cells were then heat shocked for 20 min at 37.5oC and allowed to recover for 1.5 h at room temperature prior to analysis of CAT activity. Figure 5 shows that the C-terminal half of Drosophila HSF comprising residues 321-691 (construct I) was capable of robust transactivation. The level of CAT activity, normalized to the GAL4 DNA binding activity, was 28.6% for this construct, about one-third the level that was conferred by the viral transactivator VP16 (pGVP16), set at 100%. The level of CAT activity was progressively reduced as the C-terminal end was truncated to residue 674 (construct II; 16%), to residue 655 (construct III, 12.7%), and to residue 629 (construct IV; 9.5%). Further deletions to residues 609, 602, 585 and 536 abolished transactivation by the chimeric factors to undetectable levels. The absence of CAT activity for these constructs did not result from a lack of GAL4-HSF expression as the expressed proteins could be visualized by Western blot analysis using polyclonal antibody against Drosophila HSF (Fig. 5 B), nor from the lack of DNA binding activity as determined by the electric mobility shift assay (Fig. 5 C). Hence, the results define a transactivation domain for Drosophila HSF that lies from residue 610, downstream of the C-terminal leucine zipper, to the end of the protein at residue 691.

N-terminal deletions of Drosophila HSF from residues 321-610 (constructs IX-XIII) did not result in a reduction of the ability of the GAL4-HSF chimeras to activate CAT expression (Fig. 5 ). Instead, when internal sequences between 405 and 610 were removed (constructs XI-XIII), the overall level of CAT activity was increased by up to several-fold of the undeleted construct, suggesting that parts of this internal region may participate in negative regulation of the transactivation domain. We have also analyzed the function of the transactivation domain of HSF in the absence of the negative regulatory region by combining the progressive C-terminal deletions from constructs II, III and IV with the deletion of residues 349-609 in construct XIII. In general agreement with the results shown above, the deletions from the C-terminus of HSF in this context also revealed progressive reduction of CAT activity (constructs XIV, XV and XVI) (Fig. 6 ).


Figure 8 . Comparison of C-terminal regions of Drosophila HSF and human HSF1. Identical amino acids are dark shaded and conservative exchanges are light-shaded, while diamonds highlight residues forming hydrophobic heptad repeat (zipper 4). Gaps introduced for sequence alignment are indicated by dashes.

Stress-independent transactivation by GAL4-HSF chimeras and functional replacement with the C-terminal region of human HSF1

To assess the ability of GAL4-HSF chimeras to respond to heat stress, the activity of GAL4-HSF constructs was determined in both control and heat shocked cells. Analysis of CAT levels accumulating with or without heat shock treatment revealed that all GAL-HSF constructs were able to constitutively activate the target promoter. No significant increase of CAT activity could be quantified when the transfected cells were subjected to heat shock. Representative examples (constructs I and XII) are shown in Figure 7 A.

It is known that the yeast HSFs as well as the tomato HSFs contain potent C-terminal transactivation domains ( 30 , 45 - 47 ). Recently a transactivation function was also ascribed to the C-terminus of human HSF1 ( 52 ). To investigate if the human HSF1 C-terminal region can function in Drosophila cells, we substituted the 3'-end region of Drosophila HSF with the equivalent region of the human protein (construct XVII). Figure 7 B shows that this chimeric factor could function efficiently as a transactivator in Drosophila cells. Hence, the C-terminal transactivation domain is functionally conserved between human and insect HSFs.

DISCUSSION

To analyze regions of Drosophila HSF involved in transactivation of target genes we constructed chimeric genes composed of the DNA binding domain of the yeast transcription factor GAL4 fused to various segments derived from the C-terminal half of HSF. After transfection, the constructs were shown to yield chimeric proteins which were constitutively localized to the cell nucleus and exhibited DNA binding activity independent of heat shock. Analysis of the ability of the GAL4-HSF proteins to activate transcription of a CAT reporter gene revealed that transactivation required HSF residues 610-691. This domain of 80 amino acids is located immediately C-terminal to leucine zipper 4, previously implicated in controlling the inactive, monomeric conformation of HSF ( 18 ); hence, leucine zipper 4 is dispensable for transactivation.

Our results also revealed stress-independent negative regulation of the transactivation domain imposed by an internal region located between residues 405-610 of Drosophila HSF. It is of interest that a study of GAL4-human HSF1 chimeras in human cells ( 52 ) also showed that a corresponding region of HSF1 conserved between human and chicken factors could negatively regulate the C-terminal transactivation domain; in this case however, the negative regulation was relieved upon heat shock. The disparity in the response to heat stress could be due to the cell type-specific nature of such heat-inducible transactivation, which was observed in HeLa cells but not in COS cells ( 52 ).

Although we were unable to clearly identify domains important for the heat shock regulation of transactivation in the C-terminal half of Drosophila HSF, it is probable that such regions may exist in the N-terminal parts of HSF absent from the chimeras analyzed in this study. Regions important for the suppression of transactivation under normal conditions have been mapped to the N-terminal half of yeast HSF including leucine zippers 1-3 ( 45 , 46 , 48 ). Indeed, after submission of this manuscript, two studies ( 59 , 60 ) have reported contributions of the N-terminal regions of human HSF1 towards regulating the transactivation domain in a heat shock-dependent manner. It will be of interest to confirm such regions in Drosophila HSF by additional studies.

Potent C-terminal transactivation domains encompassing leucine zipper motifs were described in HSFs from yeast Saccharomyces cerevisiae and Kluyveromyces lactis ( 45 - 47 ). In the case of tomato HSFs, the transactivation domain was localized near the C-terminus and a structural repeat containing conserved tryptophan residues was suggested to be involved in transactivation ( 30 ). Recently, a transactivation domain was mapped to the C-terminus of human HSF1 ( 52 , 59 , 60 ). The location of the transactivation domain near the C-terminus of Drosophila HSF demonstrates a similarity in the overall organization of HSF between insects, plants and vertebrates.

Comparison of Drosophila HSF and human HSF1 protein C-terminal sequences shown in Figure 8 reveals the expected similarities in the conserved leucine zipper 4 region important for regulating trimer formation. In the adjacent C-terminal region, there are many conservative exchanges between Drosophila HSF and human HSF1. The whole region contains abundant hydrophobic and acidic residues in contrast to very few basic amino acids. The importance of these residues in the function of the Drosophila HSF will require more detailed mutagenesis studies. It is of interest that the C-terminal region of human HSF1 is able to functionally substitute for the corresponding region of Drosophila HSF, suggesting the possibility of a structural conservation, despite limited sequence identity.

ACKNOWLEDGEMENTS

We would like to thank all members of our laboratory for critical comments during preparation of this manuscript. This work was supported by the intramural research program of the National Cancer Institute. R.A. was a Howard Hughes Medical Institute-National Institutes of Health Research Scholar.

REFERENCES

1 Schlesinger, M. J., Ashburner, M. and Tissieres, A. (eds) (1982) Heat Shock from Bacteria to Man. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

2 Lanks, K. W. (1983) Proc. Natl. Acad. Sci. USA, 80, 5325-5329. MEDLINE Abstract

3 Lindquist, S. (1986) Annu. Rev. Biochem., 55, 1151-1191. MEDLINE Abstract

4 Lindquist, S. and Craig, E. A. (1988) Annu. Rev. Genet., 22, 631-677. MEDLINE Abstract

5 Morimoto, R. I., Tissieres, A. and Georgopoulos, C. (eds) (1990) Stress Proteins in Biology and Medicine. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

6 Morimoto, R. I., Tissieres, A. and Georgopoulos, C. (eds) (1994) The Biology of Heat Shock Proteins and Molecular Chaperones. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

7 Lis, J. T. and Wu, C. (1992) In McKnight, S. L., and Yamamoto, K. R. (eds), Transcriptional Regulation. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, Vol.II, pp. 907-930.

8 Lis, J. T. and Wu, C. (1993) Cell, 74, 1-20. MEDLINE Abstract

9 Morimoto, R. I., Jurivich, D. A., Kroeger, P. E., Mathur, S. K., Murphy, S. P., Nakai, A., Sarge, K., Abravaya, K. and Sistonen, L. T. (1994) In Morimoto, R. I., Tissieres, A., and Georgopoulos, C. (eds), The Biology of Heat Shock Proteins and Molecular Chaperones. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 417-456.

10 Wu, C., Clos, J., Giorgi, G., Haroun, R. I., Kim, S.-J., Rabindran, S. K., Westwood, J. T., Wisniewski, J. and Yim, G. (1994) In Morimoto, R. I., Tissieres, A., and Georgopoulos, C. (eds), The Biology of Heat Shock Proteins and Molecular Chaperones. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 395-416.

11 Fernandes, M., Xiao, H. and Lis, J. T. (1994) Nucleic Acids Res., 22, 167-73. MEDLINE Abstract

12 Amin, J., Ananthan, J. and Voellmy, R. (1988) Mol. Cell. Biol., 8, 3761-3769. MEDLINE Abstract

13 Pelham, H. R. and Bienz, M. (1982) EMBO J., 1, 1473-1477. MEDLINE Abstract

14 Pelham, H. R. B. (1982) Cell, 30, 517-528. MEDLINE Abstract

15 Perisic, O., Xiao, H. and Lis, J. T. (1989) Cell, 59, 797-806. MEDLINE Abstract

16 Xiao, H. and Lis, J. T. (1988) Science, 239, 1139-1142. MEDLINE Abstract

17 Peteranderl, R. and Nelson, H. C. (1992) Biochemistry, 31, 12272-12276. MEDLINE Abstract

18 Rabindran, S. K., Haroun, R. I., Clos, J., Wisniewski, J. and Wu, C. (1993) Science, 259, 230-234. MEDLINE Abstract

19 Sarge, K. D., Murphy, S. P. and Morimoto, R. I. (1993) Mol. Cell. Biol., 13, 1392-1407. MEDLINE Abstract

20 Sorger, P. K. and Nelson, H. C. (1989) Cell, 59, 807-813. MEDLINE Abstract

21 Westwood, J. T. and Wu, C. (1993) Mol. Cell. Biol., 13, 3481-3486. MEDLINE Abstract

22 Westwood, J. T., Clos, J. and Wu, C. (1991) Nature, 353, 822-827. MEDLINE Abstract

23 Sorger, P. K. (1991) Cell, 65, 363-366. MEDLINE Abstract

24 Hensold, J. O., Hunt, C. R., Calderwood, S. K., Housman, D. E. and Kingston, R. E. (1990) Mol. Cell. Biol., 10, 1600-1608. MEDLINE Abstract

25 Jurivich, D. A., Sistonen, L., Kroes, R. A. and Morimoto, R. I. (1992) Science, 255, 1243-1245. MEDLINE Abstract

26 Clos, J., Westwood, J. T., Becker, P. B., Wilson, S., Lambert, K. and Wu, C. (1990) Cell, 63, 1085-1097. MEDLINE Abstract

27 Rabindran, S. K., Giorgi, G., Clos, J. and Wu, C. (1991) Proc. Natl. Acad. Sci. USA, 88, 6906-6910. MEDLINE Abstract

28 Zuo, J., Baler, R., Dahl, G. and Voellmy, R. (1994) Mol. Cell. Biol., 14, 7557-7568. MEDLINE Abstract

29 Clos, J., Rabindran, S., Wisniewski, J. and Wu, C. (1993) Nature, 364, 252-255. MEDLINE Abstract

30 Treuter, E., Nover, L., Ohme, K. and Scharf, K. D. (1993) Mol. Gen. Genet., 240, 113-125. MEDLINE Abstract

31 Sarge, K. D., Zimarino, V., Holm, K., Wu, C. and Morimoto, R. I. (1991) Genes Dev., 5, 1902-1911. MEDLINE Abstract

32 Baler, R., Dahl, G. and Voellmy, R. (1993) Mol. Cell. Biol., 13, 2486-2496. MEDLINE Abstract

33 Abravaya, K., Phillips, B. and Morimoto, R. I. (1991) Genes Dev., 5, 2117-2127. MEDLINE Abstract

34 Abravaya, K., Myers, M. P., Murphy, S. P. and Morimoto, R. I. (1992) Genes Dev., 6, 1153-1164. MEDLINE Abstract

35 Schlesinger, M. J. and Ryan, C. (1993) Protein Sci., 2, 1356-1360. MEDLINE Abstract

36 Baler, R., Welch, W. J. and Voellmy, R. (1992) J. Cell. Biol., 117, 1151-1159. MEDLINE Abstract

37 Mosser, D. D., Duchaine, J. and Massie, B. (1993) Mol. Cell. Biol., 13, 5427-5438. MEDLINE Abstract

38 Nadeau, K., Das, A. and Walsh, C. T. (1993) J. Biol. Chem., 268, 1479-1487. MEDLINE Abstract

39 Rabindran, S. K., Wisniewski, J., Li, L., Li, G. C. and Wu, C. (1994) Mol. Cell. Biol., 14, 6552-6560. MEDLINE Abstract

40 Jakobsen, B. K. and Pelham, H. R. (1988) Mol. Cell. Biol., 8, 5040-5042. MEDLINE Abstract

41 Gross, D. S., English, K. E., Collins, K. W. and Lee, S. W. (1990) J. Mol. Biol., 216, 611-631. MEDLINE Abstract

42 Sorger, P. K., Lewis, M. J. and Pelham, H. R. (1987) Nature, 329, 81-84. MEDLINE Abstract

43 Giardina, C. and Lis, J. T. (1995) Mol. Cell. Biol., 15, 3354-3362. MEDLINE Abstract

44 Sorger, P. K. and Pelham, H. R. (1988) Cell, 54, 855-864. MEDLINE Abstract

45 Nieto-Sotelo, J., Wiederrecht, G., Okuda, A. and Parker, C. S. (1990) Cell, 62, 807-817.

46 Bonner, J. J., Heyward, S. and Fackenthal, D. L. (1992) Mol. Cell. Biol., 12, 1021-1030. MEDLINE Abstract

47 Chen, Y., Barlev, N. A., Westergaard, O. and Jakobsen, B. K. (1993) EMBO J., 12, 5007-5018. MEDLINE Abstract

48 Sorger, P. K. (1990) Cell, 62, 793-805. MEDLINE Abstract

49 Jakobsen, B. K. and Pelham, H. R. (1991) EMBO J., 10, 369-375. MEDLINE Abstract

50 Hoj, A. and Jakobsen, B. K. (1994) EMBO J., 13, 2617-2624. MEDLINE Abstract

51 Boorstein, W. R. and Craig, E. A. (1990) Mol. Cell. Biol., 10, 3262-3267. MEDLINE Abstract

52 Green, M., Schuetz, T. J., Sullivan, E. K. and Kingston, R. E. (1995) Mol. Cell. Biol., 15, 3354-3362. MEDLINE Abstract

53 Fujii, M., Tsuchiya, H. and Seiki, M. (1991) Oncogene, 6, 2349-2352. MEDLINE Abstract

54 Bunch, T. A., Grinblat, Y. and Goldstein, L. S. (1988) Nucleic Acids Res., 16, 1043-1061. MEDLINE Abstract

55 Zimarino, V., Tsai, C. and Wu, C. (1990) Mol. Cell. Biol., 10, 752-759. MEDLINE Abstract

56 Fisher, J. A., Giniger, E., Maniatis, T. and Ptashne, M. (1988) Nature, 332, 853-856. MEDLINE Abstract

57 Silver, P. A., Brent, R. and Ptashne, M. (1986) Mol. Cell. Biol., 6, 4763-4766. MEDLINE Abstract

58 Nelson, M. and Silver, P. (1989) Mol. Cell. Biol., 9, 384-389. MEDLINE Abstract

59 Shi, Y., Kroeger, P.E., and Morimoto, R.I. (1995) Mol. Cell. Biol., 15, 4309-4318. MEDLINE Abstract

60 Zuo, J., Rungger, D., and Voellmy, R. (1995) Mol. Cell. Biol., 15, 4319-4330. MEDLINE Abstract


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
Y. V. Wang, H. Tang, and D. S. Gilmour
Identification In Vivo of Different Rate-Limiting Steps Associated with Transcriptional Activators in the Presence and Absence of a GAGA Element
Mol. Cell. Biol., May 1, 2005; 25(9): 3543 - 3552.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. W. Kim, Y.-J. Kwon, J. M. Kim, Y.-H. Song, S. N. Kim, and Y.-J. Kim
MED16 and MED23 of Mediator are coactivators of lipopolysaccharide- and heat-shock-induced transcriptional activators
PNAS, August 17, 2004; 101(33): 12153 - 12158.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. M. Park, J. M. Kim, L. K. Kim, S. N. Kim, J. Kim-Ha, J. H. Kim, and Y.-J. Kim
Signal-Induced Transcriptional Activation by Dif Requires the dTRAP80 Mediator Module
Mol. Cell. Biol., February 15, 2003; 23(4): 1358 - 1367.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
J. T. Lis, P. Mason, J. Peng, D. H. Price, and J. Werner
P-TEFb kinase recruitment and function at heat shock loci
Genes & Dev., April 1, 2000; 14(7): 792 - 803.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
A. T. Hoang, J. Huang, N. Rudra-Ganguly, J. Zheng, W. C. Powell, S. K. Rabindran, C. Wu, and P. Roy-Burman
A Novel Association between the Human Heat Shock Transcription Factor 1 (HSF1) and Prostate Adenocarcinoma
Am. J. Pathol., March 1, 2000; 156(3): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
P. Döring, E. Treuter, C. Kistner, R. Lyck, A. Chen, and L. Nover
The Role of AHA Motifs in the Activator Function of Tomato Heat Stress Transcription Factors HsfA1 and HsfA2
PLANT CELL, February 1, 2000; 12(2): 265 - 278.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Tanabe, N. Sasai, K. Nagata, X.-D. Liu, P. C. C. Liu, D. J. Thiele, and A. Nakai
The Mammalian HSF4 Gene Generates Both an Activator and a Repressor of Heat Shock Genes by Alternative Splicing
J. Biol. Chem., September 24, 1999; 274(39): 27845 - 27856.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zhong, S.-J. Kim, and C. Wu
Sensitivity of Drosophila Heat Shock Transcription Factor to Low pH
J. Biol. Chem., January 29, 1999; 274(5): 3135 - 3140.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
P. Mercier, N. Winegarden, and J. Westwood
Human heat shock factor 1 is predominantly a nuclear protein before and after heat stress
J. Cell Sci., January 8, 1999; 112(16): 2765 - 2774.
[Abstract] [PDF]


Home page
Genes Dev.Home page
R. I. Morimoto
Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators
Genes & Dev., December 15, 1998; 12(24): 3788 - 3796.
[Full Text]


Home page
Plant Physiol.Home page
F. Schöffl, R. Prändl, and A. Reindl
Regulation of the Heat-Shock Response
Plant Physiology, August 1, 1998; 117(4): 1135 - 1141.
[Full Text]


Home page
Cold Spring Harb Symp Quant BiolHome page
C. WU, T. TSUKIYAMA, D. GDULA, P. GEORGEL, M. MARTINEZ-BALBAS, G. MIZUGUCHI, V. OSSIPOW, R. SANDALTZOPOULOS, and H.-M. WANG
ATP-dependent Remodeling of Chromatin
Cold Spring Harb Symp Quant Biol, January 1, 1998; 63(0): 525 - 534.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
P. B. Mason Jr. and J. T. Lis
Cooperative and Competitive Protein Interactions at the Hsp70 Promoter
J. Biol. Chem., December 26, 1997; 272(52): 33227 - 33233.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. A. Mercier, J. Foksa, N. Ovsenek, and J. T. Westwood
Xenopus Heat Shock Factor 1 Is a Nuclear Protein before Heat Stress
J. Biol. Chem., May 30, 1997; 272(22): 14147 - 14151.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (156K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Wisniewski, J
Right arrow Articles by Wu, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wisniewski, J
Right arrow Articles by Wu, C
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?